BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25707371)

  • 21. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.
    Mohamed M; Clabots C; Porter SB; Thuras P; Johnson JR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4638-45. PubMed ID: 27185805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients.
    Ho PL; Chu YP; Lo WU; Chow KH; Law PY; Tse CW; Ng TK; Cheng VC; Que TL
    J Med Microbiol; 2015 Mar; 64(Pt 3):243-247. PubMed ID: 25587081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.
    Adams-Sapper S; Diep BA; Perdreau-Remington F; Riley LW
    Antimicrob Agents Chemother; 2013 Jan; 57(1):490-7. PubMed ID: 23147723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland.
    Seiffert SN; Hilty M; Kronenberg A; Droz S; Perreten V; Endimiani A
    J Antimicrob Chemother; 2013 Oct; 68(10):2249-54. PubMed ID: 23759671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Population-Based Surveillance Study of Shared Genotypes of Escherichia coli Isolates from Retail Meat and Suspected Cases of Urinary Tract Infections.
    Yamaji R; Friedman CR; Rubin J; Suh J; Thys E; McDermott P; Hung-Fan M; Riley LW
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR; Johnston B; Kuskowski MA; Sokurenko EV; Tchesnokova V
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4471-80. PubMed ID: 25987621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea.
    Kim SY; Park YJ; Johnson JR; Yu JK; Kim YK; Kim YS
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):97-101. PubMed ID: 26643062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
    Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Escherichia coli ST131-
    Liu CM; Stegger M; Aziz M; Johnson TJ; Waits K; Nordstrom L; Gauld L; Weaver B; Rolland D; Statham S; Horwinski J; Sariya S; Davis GS; Sokurenko E; Keim P; Johnson JR; Price LB
    mBio; 2018 Aug; 9(4):. PubMed ID: 30154256
    [No Abstract]   [Full Text] [Related]  

  • 31. Genotypic analysis of uropathogenic Escherichia coli to understand factors that impact the prevalence of β-lactam-resistant urinary tract infections in a community.
    Tarlton NJ; Moritz C; Adams-Sapper S; Riley LW
    J Glob Antimicrob Resist; 2019 Dec; 19():173-180. PubMed ID: 30872040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
    J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Multiplex PCR Method and Genome Sequence-Based Analog for High-Resolution Subclonal Assignment and Characterization of Escherichia coli Sequence Type 131 Isolates.
    Johnston BD; Gordon DM; Burn S; Johnson TJ; Weber BP; Miller EA; Johnson JR
    Microbiol Spectr; 2022 Jun; 10(3):e0106422. PubMed ID: 35604132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
    Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Population structure of drug-susceptible,-resistant and ESBL-producing Escherichia coli from community-acquired urinary tract".
    Hertz FB; Nielsen JB; Schønning K; Littauer P; Knudsen JD; Løbner-Olesen A; Frimodt-Møller N
    BMC Microbiol; 2016 Apr; 16():63. PubMed ID: 27067536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
    Harris PNA; Ben Zakour NL; Roberts LW; Wailan AM; Zowawi HM; Tambyah PA; Lye DC; Jureen R; Lee TH; Yin M; Izharuddin E; Looke D; Runnegar N; Rogers B; Bhally H; Crowe A; Schembri MA; Beatson SA; Paterson DL;
    J Antimicrob Chemother; 2018 Mar; 73(3):634-642. PubMed ID: 29253152
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Johnson JR; Johnston B; Thuras P; Launer B; Sokurenko EV; Miller LG
    mSphere; 2016; 1(6):. PubMed ID: 27904884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic analysis uncovers a phenotypically diverse but genetically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract infections.
    Clark G; Paszkiewicz K; Hale J; Weston V; Constantinidou C; Penn C; Achtman M; McNally A
    J Antimicrob Chemother; 2012 Apr; 67(4):868-77. PubMed ID: 22258927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.
    Kang CI; Cha MK; Kim SH; Ko KS; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    J Korean Med Sci; 2013 Jul; 28(7):998-1004. PubMed ID: 23853481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.
    Banerjee R; Johnston B; Lohse C; Chattopadhyay S; Tchesnokova V; Sokurenko EV; Johnson JR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5912-7. PubMed ID: 24041881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.